Achieve Life Sciences (ACHV) Reaches New 1-Year Low at $1.85

Achieve Life Sciences Inc (NASDAQ:ACHV) hit a new 52-week low during trading on Wednesday . The company traded as low as $1.85 and last traded at $1.93, with a volume of 6655 shares. The stock had previously closed at $2.05.

Separately, LADENBURG THALM/SH SH initiated coverage on shares of Achieve Life Sciences in a report on Monday, August 20th. They set a “buy” rating and a $12.00 price target for the company.

The firm has a market capitalization of $9.88 million, a P/E ratio of -0.09 and a beta of 1.88.



Achieve Life Sciences (NASDAQ:ACHV) last issued its quarterly earnings results on Wednesday, August 8th. The biopharmaceutical company reported ($1.82) EPS for the quarter. As a group, equities analysts predict that Achieve Life Sciences Inc will post -6.61 earnings per share for the current fiscal year.

About Achieve Life Sciences (NASDAQ:ACHV)

Achieve Life Sciences, Inc, a clinical-stage pharmaceutical company, develops and commercializes smoking cessation aids in the United States and internationally. The company offers Cytisine, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms.

Featured Article: What are retained earnings?

Receive News & Ratings for Achieve Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Achieve Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply